ID: ALA3331378

Max Phase: Preclinical

Molecular Formula: C15H15BrN5O7P

Molecular Weight: 488.19

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=P(O)(O)OC[C@H]1O[C@@H](n2cnc3c(-c4cncc(Br)c4)ncnc32)[C@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C15H15BrN5O7P/c16-8-1-7(2-17-3-8)10-11-14(19-5-18-10)21(6-20-11)15-13(23)12(22)9(28-15)4-27-29(24,25)26/h1-3,5-6,9,12-13,15,22-23H,4H2,(H2,24,25,26)/t9-,12-,13-,15-/m1/s1

Standard InChI Key:  HJHZKPCHXUMEBE-QGMIFYJMSA-N

Associated Targets(Human)

DNPH1 Tchem 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 (25 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Dnph1 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 (25 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 488.19Molecular Weight (Monoisotopic): 486.9892AlogP: 0.38#Rotatable Bonds: 5
Polar Surface Area: 172.94Molecular Species: ACIDHBA: 10HBD: 4
#RO5 Violations: 0HBA (Lipinski): 12HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 1.20CX Basic pKa: 2.48CX LogP: -1.77CX LogD: -3.93
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.37Np Likeness Score: 0.58

References

1. Amiable C, Paoletti J, Haouz A, Padilla A, Labesse G, Kaminski PA, Pochet S..  (2014)  6-(Hetero)Arylpurine nucleotides as inhibitors of the oncogenic target DNPH1: synthesis, structural studies and cytotoxic activities.,  85  [PMID:25108359] [10.1016/j.ejmech.2014.07.110]

Source